A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
Despite significant efforts, vaccines are not yet available for every infectious pathogen, and the search for a protective approach to prevent the establishment of chronic infections, i.e., with HIV, continues. Immune checkpoint therapies targeting inhibitory receptors, such as PD-1, have shown imp...
Saved in:
Main Authors: | Torben Knuschke, Sebastian Kollenda, Christina Wenzek, Gennadiy Zelinskyy, Philine Steinbach, Ulf Dittmer, Jan Buer, Matthias Epple, Astrid M. Westendorf |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c4b0311ffd9843a69b3db45c416f2a05 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth
by: Johanna C. Klein, et al.
Published: (2017) -
Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection.
by: Kathrin Gibbert, et al.
Published: (2012) -
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
by: David H. Peng, et al.
Published: (2020) -
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation
by: Alexander Roberts, et al.
Published: (2021) -
Metabolic requirements of NK cells during the acute response against retroviral infection
by: Elisabeth Littwitz-Salomon, et al.
Published: (2021)